• Please note that we do not deliver goods between 19.12.2019 and 03.01.2020 due to public holidays. However, we are happy to accept orders for deliveries in 2020 during this period.

CpG Oligodeoxynucleotides

CpG Oligodeoxynucleotides (ODN) are small single-stranded DNA molecules containing CpG motifs. Their backbone is partially or completely phosphothioated. ODNs whose CpG motifs are unmethylated are recognized by pattern-recognition-receptors (PRR) like Toll-like Receptor 9 (TLR9) and act as immunostimulants. CpG Oligodeoxynucleotides induce cytokine and interferon production, B-cell and monocyte maturation and the activation of NK-cells and plasmocytoid dendritic cells. CpG Oligodeoxynucleotides are therefore used as adjuvants and in cancer therapy. ODNs containing a TTAGGG-motiv however are TLR9-Antagonists and have immunosuppressive effects.

CpG Oligodeoxynucleotides (ODN) are small single-stranded DNA molecules containing CpG motifs. Their backbone is partially or completely phosphothioated. ODNs whose CpG motifs are unmethylated are... read more »
Close window
CpG Oligodeoxynucleotides

CpG Oligodeoxynucleotides (ODN) are small single-stranded DNA molecules containing CpG motifs. Their backbone is partially or completely phosphothioated. ODNs whose CpG motifs are unmethylated are recognized by pattern-recognition-receptors (PRR) like Toll-like Receptor 9 (TLR9) and act as immunostimulants. CpG Oligodeoxynucleotides induce cytokine and interferon production, B-cell and monocyte maturation and the activation of NK-cells and plasmocytoid dendritic cells. CpG Oligodeoxynucleotides are therefore used as adjuvants and in cancer therapy. ODNs containing a TTAGGG-motiv however are TLR9-Antagonists and have immunosuppressive effects.

1 from 3 pages
No results were found for the filter!
G-type iODN (inhibitory ODN) Endotoxin-free (sterile)
G-type iODN (inhibitory ODN) Endotoxin-free (sterile)

Item number: IAX-200-052-M001

Potent sequence of an inhibitory ODN of the poly-G class I targeting TLR9, but without effect on TLR7 and TLR8 signaling, for in vivo use in rodents (50-150 µg per injection). Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
Keywords: Inhibitory ODN (iODN): Class I
Application: TLR9 competitor
MW: 6735 D
From 94.00€ *
Review
ODN 2138 (Control for ODN 1826) Endotoxin-free (sterile)
ODN 2138 (Control for ODN 1826) Endotoxin-free (sterile)

Item number: IAX-200-201-C100

Negative control GpC ODN for in vivo use in rodents (50-150 µg per injection). As active compound use CpG ODN 1826 (Cat. No.: IAX-200-002). For negative control without agonistic nor antagonistic activity: Neutral-ODN (Cat. No.: IAX-200-202).
Application: Negative Control for ODN 1826 (IAX-200-002)
MW: 6383 D
94.00€ *
Review
Polyinosinic-polycytidylic acid [Poly(I:C)] Endotoxin-free (sterile)
Polyinosinic-polycytidylic acid [Poly(I:C)]...

Item number: IAX-200-021-M005

Activates TLR3, MDA5/Helicard and RIG-I. Optimal working concentration depends upon target receptor accessibility, number, density, as well as cell type, and therefore needs to be determined for each application. Recommended concentration range: in vitro: 0.5-10 µg/ml, in vivo: 5mg/kg.
Keywords: Polyinosinic-polycytidylic acid, potassium salt (poly (I:C))
Application: TLR3, MDA5/Helicard, RIG-I activator
From 108.00€ *
Review
ODN 1668 (Type B) Endotoxin-free (sterile)
ODN 1668 (Type B) Endotoxin-free (sterile)

Item number: IAX-200-001-M001

3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 1720 (Cat. No.: IAX-200-200).
Keywords: CpG ODN TLR9 Agonist: B Type (species: rodent)
Application: TLR9 activator
MW: 6383 D
From 119.00€ *
Review
ODN M362 (Type C) Endotoxin-free (sterile)
ODN M362 (Type C) Endotoxin-free (sterile)

Item number: IAX-200-004-M001

Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2243 (Cat. No.: IAX-200-205).
Keywords: CpG ODN TLR9 Agonist: A Type (species: human and rodent)
Application: TLR9 activator
MW: 6644 D
From 119.00€ *
Review
ODN 1826 (Type B) Endotoxin-free (sterile)
ODN 1826 (Type B) Endotoxin-free (sterile)

Item number: IAX-200-002-M001

Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 1982 (Cat. No.: IAX-200-201).
Keywords: CpG ODN TLR9 Agonist: B Type (species: rodent)
Application: TLR9 activator
Reactivity: Mouse, Rat
MW: 6383 D
From 119.00€ *
Review
ODN 2006 (Type B) Endotoxin-free (sterile)
ODN 2006 (Type B) Endotoxin-free (sterile)

Item number: IAX-200-006-M001

3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.7-7.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2137 (Cat. No.: IAX-200-206).
Keywords: CpG ODN TLR9 Agonist: B Type (species: human and rodent)
Application: TLR9 activator
MW: 7720 D
From 119.00€ *
Review
ODN 1585 (Type A) Endotoxin-free (sterile)
ODN 1585 (Type A) Endotoxin-free (sterile)

Item number: IAX-200-003-M001

Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2218 (Cat. No.: IAX-200-203). Unmethylated CG dinucleotides within particular sequence contexts are responsible for the...
Keywords: CpG ODN TLR9 Agonist: A Type (species: rodent)
Application: TLR9 activator
MW: 6643 D
From 119.00€ *
Review
ODN 2216 (Type A) Endotoxin-free (sterile)
ODN 2216 (Type A) Endotoxin-free (sterile)

Item number: IAX-200-005-C100

Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2243 (Cat. No.: IAX-200-205).
Keywords: CpG ODN TLR9 Agonist: A Type (species: human and rodent)
Application: TLR9 activator
MW: 6644 D
From 119.00€ *
Review
iODN (inhibitory ODN) 2088 Endotoxin-free (sterile)
iODN (inhibitory ODN) 2088 Endotoxin-free (sterile)

Item number: IAX-200-050-3001

Potent sequence of an inhibitory ODN for in vivo use in rodents (50-150 µg per injection): prototype class I, may also affect TLR7 and TLR8 signaling. Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
Keywords: Inhibitory ODN (iODN): Class I
Application: TLR9 competitor
MW: 4887 D
From 94.00€ *
Review
Neutral-ODN (Control for iODNs) Endotoxin-free (sterile)
Neutral-ODN (Control for iODNs) Endotoxin-free (sterile)

Item number: IAX-200-202-3001

3 x 1 mg. Negative control GpC ODN for in vivo use in rodents (50-150 µg per injection). As active compound use CpG ODN 1585 (Cat. No.: IAX-200-003). For negative control without agonistic nor antagonistic activity: Neutral-ODN (Cat. No.: IAX-200-202).
Application: Negative Control for ODN 1585 (IAX-200-003)
MW: 4821 D
From 94.00€ *
Review
ODN 2395 (Type C) Endotoxin-free (sterile)
ODN 2395 (Type C) Endotoxin-free (sterile)

Item number: IAX-200-007-C100

3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.7-7.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
Keywords: CpG ODN: C Type (species: human and rodent)
Application: TLR9 activator
MW: 7068 D
From 119.00€ *
Review
1 from 3 pages
Viewed